COSTA MESA, CA NMUS, (Marketwired May 17, 2017) NEMUS Bioscience, Inc. (OTCQB: NMUS) announced that patents have been granted in Canada and Hong Kong covering the company s proprietary prodrug of THC, THC-valine-hemisuccinate (THCVHS), as well as other amide-ester forms of cannabinoid-based molecules. These patents are licensed to Nemus by the University of Mississippi, and further broaden the potential commercial territories for THCVHS. The molecule has already received patent coverage in the United States, Japan, the United Kingdom, the
http://bit.ly/2rqN48p
No comments:
Post a Comment